STIM Neuronetics Inc
Company Analysis
Latest News
🟢 Neuronetics is trading 5.88% up today with no fresh company-specific catalyst identified
Neuronetics is trading 5.88% up now at $2.88, with no fresh company-specific catalyst identified. - No fresh company-specific announcement, earnings release,...
🟢 Neuronetics is trading 7.94% up in pre-market with no fresh company-specific catalyst identified
Neuronetics is trading 7.94% up at $2.99 after no fresh company-specific catalyst was identified for September 3, 2026. - Latest confirmed developments were...
🟢 Neuronetics is trading 5.3% up in pre-market with no confirmed catalyst
Neuronetics is trading 5.28% up at $2.99 in pre-market on September 1, 2026, with no confirmed company-specific catalyst identified. - Recent second-quarter...
🔴 Neuronetics is trading 5.3% down today with no clear company-specific catalyst
Neuronetics is trading 5.3% down now at $2.79, with no clear company-specific announcement, earnings update, analyst action, or other direct catalyst dated...
🟢 Neuronetics is trading 5% up in pre-market as catalyst remains unclear
Neuronetics is trading 5.37% up in pre-market at $3.14, rising from the August 25 close of $2.98; no clear catalyst has been identified. - No company-specific...
🔴 Neuronetics is trading 7.3% down in pre-market — specific reason remains unclear
Neuronetics is trading at $2.76, down -7.34% in pre-market; the specific reason remains unclear. - No company-specific announcement, filing, downgrade, or...
🟢 Neuronetics is trading 6% up in pre-market today as healthcare rises 1.55% pre-market
Neuronetics is trading 6.05% up in pre-market at $3.33; healthcare-sector momentum is the most likely explanation. - Healthcare is up 1.55% pre-market as...
🔴 Neuronetics is trading 5.1% down today as Treasury yields and oil rise
Neuronetics is trading at $3.10 (-5.05%) as broader market weakness pressures growth-oriented stocks; no clear company-specific negative announcement emerged...
🟢 Neuronetics is trading 5% up today after revenue beat and first positive adjusted EBITDA
Neuronetics is trading 5% up now at $3.19 after investors continued responding to its August 11 earnings release. - Second-quarter revenue reached $41.6...
🟢 Neuronetics is trading 5% up today after Q2 earnings beat
Neuronetics is trading 5.3% up now at $3.38 after investors continued digesting its August 11 earnings beat. - Second-quarter revenue reached $41.6 million,...
🟢 Neuronetics is trading 37.79% up today after Q2 beat and positive adjusted EBITDA
Neuronetics is trading 37.79% higher at $2.99 after its August 11, 2026, second-quarter results exceeded expectations. - Revenue reached $41.6 million;...
Neuronetics second quarter 2026 revenue of $41.6M beat estimates while reaching positive adjusted EBITDA
Neuronetics reported second quarter 2026 revenue of $41.6 million, significantly exceeding analyst estimates. While consolidated revenue grew 9.1%...
Neuronetics Shares Surge 11% Ahead of Q2 Earnings — Can a New CEO and Shrinking Losses Justify the Rally?
Shares shifted sharply higher in pre-market trading as Neuronetics (STIM) prepared to report second-quarter 2026 results before the opening bell. Analysts...
🟢 Neuronetics surges 11.06% in pre-market following strong Q2 2026 results
Neuronetics is trading 11.06% up at $2.41 after reporting robust second-quarter 2026 financial results. The company reported Q2 2026 revenue of $41.6 million,...
🟢 Neuronetics is trading 6.91% up in pre-market ahead of second-quarter 2026 results
Neuronetics is trading 6.91% up now at $2.32 in pre-market, primarily on positioning ahead of its scheduled second-quarter 2026 financial results release...
🔴 Neuronetics is trading 10.08% down today — no clear company-specific announcement identified
Neuronetics is trading 10.08% down at $2.14, with no clear company-specific announcement identified to explain the decline during early trading. - Compared...
🔴 Neuronetics is trading 7.77% down today
Neuronetics is trading 7.77% down at $2.19, reversing its August 7, 2026 close of $2.38; the reason remains uncertain. - No clear company-specific...
Neuronetics Inc Q2 2026 Earnings Preview: What Analysts Expect on August 11, 2026
Neuronetics is expected to report Q2 2026 revenue of $21.40 million and a loss per share of $0.11, with the current stock price of $1.25 trailing significantly...
🟢 Neuronetics is trading 6.44% up with no clear company-specific catalyst identified
Neuronetics is trading 6.44% up at $2.38, with no clear company-specific catalyst identified. • No clear company-specific announcement was identified for...
🟢 Neuronetics is trading 5% up today amid healthcare sector strength and risk-on sentiment
Neuronetics is trading at $2.42 (up 5%), extending a sharp rebound that began in late July and gained momentum in early August. • The move appears driven by...